Work

Impact of Early Progression on Long Term Outcomes Among Myeloma Patients Receiving Lenalidomide, Bortezomib, and Dexamethasone (RVD) Induction Therapy

Year: 2018

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2018-99-120314

Authors: Ajay K Nooka, Jonathan L Kaufman, Charise Gleason, Nisha Joseph, Craig C Hofmeister, Lawrence H. Boise, Leonard Heffner, Madhav V Dhodapkar, Sagar Lonial

Institutions: Emory University, Winship Cancer Institute

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2912840753

Cites:

Cited by:

Related to: 10